Mapping the serum proteome to neurological diseases using whole genome sequencing
Serum proteins are easily accessible biomarkers and drug targets. Here, the authors use whole genome sequencing data to describe the genetic architecture of neurologically-relevant serum proteins and establish causal protein-neurological disease relationships.
Enregistré dans:
Auteurs principaux: | Grace Png, Andrei Barysenka, Linda Repetto, Pau Navarro, Xia Shen, Maik Pietzner, Eleanor Wheeler, Nicholas J. Wareham, Claudia Langenberg, Emmanouil Tsafantakis, Maria Karaleftheri, George Dedoussis, Anders Mälarstig, James F. Wilson, Arthur Gilly, Eleftheria Zeggini |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2f5b2a2d19854a24b3c3f873cde81d0b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Whole-genome sequencing analysis of the cardiometabolic proteome
par: Arthur Gilly, et autres
Publié: (2020) -
Whole genome sequencing and imputation in isolated populations identify genetic associations with medically-relevant complex traits
par: Lorraine Southam, et autres
Publié: (2017) -
Synergistic insights into human health from aptamer- and antibody-based proteomic profiling
par: Maik Pietzner, et autres
Publié: (2021) -
The transferability of lipid loci across African, Asian and European cohorts
par: Karoline Kuchenbaecker, et autres
Publié: (2019) -
GIGYF1 loss of function is associated with clonal mosaicism and adverse metabolic health
par: Yajie Zhao, et autres
Publié: (2021)